FOLD (amicusrx.com) Bozor qiymatining balans qiymatiga nisbati

Amicus Therapeutics Inc (FOLD) kompaniyasining rasmiy ramzlari

Amicus Therapeutics (FOLD) og'ir metabolik buzilishlarga qarshi innovatsion davolash usullarini ishlab chiqib, ilmiy hamjamiyatda benuqson obro'ga ega. Grafikdagi chiziqli narx harakati, bunda indikator 16.46 darajasida turibdi, ushbu maqomni kapital xarajatlarni kamaytirish uchun tashqi pudratchilardan foydalanadigan ishlab chiqarish modeli bilan bog'laydi. Biznes istiqbollari qat'iy xarajatlar nazoratini saqlagan holda, G'arb mamlakatlarida Pompe kasalligi terapiyasining kengayishiga bog'liq.

FOLD Amicus Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 09.05.2026 oraligʻida
Amicus Pharma original mahsuloti

Amicus Therapeutics (FOLD) kompaniyasida molekulyar skriningga AI texnologiyalarining integratsiyasi sof aktivlarda aks ettirish qiyin bo'lgan sezilarli nomoddiy qiymatni yaratadi. Ushbu bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book premium ratio) investorlarning kapitalning har bir dollaridan ortiq to'lashga tayyor bo'lgan miqdorini o'lchaydi, bu esa ushbu grafikga jismoniy resurslar qiymati va kelajakdagi dori vositalariga bo'lgan bozor kutuvlari o'rtasidagi muvozanat nuqtasini aniqlash imkonini beradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Ascendis Pharma A/S|MDGL (madrigalpharma.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated CORT|Sof aktivlarga nisbatan bozor kapitallashuvi Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Metsera Therapeutics (MTSR)|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|crinetics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Balans qiymatiga nisbatan bozor qiymati|ETNB (89bio Corp) - Bozor qiymatining balans qiymatiga nisbati|Agios Corp (AGIO) - Kapitallashuvning sof aktivlarga nisbati|GPCR (Structure Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati mimedx.com (MDXG)|Rezolute (RZLT) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati LXRX (Lexicon Pharmaceuticals Inc)|MBX Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Altimmune Pharma ALT|AARD (Aardvark Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|sagimet.com (SGMT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BIOA - Kapitallashuvning sof aktivlarga nisbati|Biomea Fusion Inc (BMEA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|QNCX (Quince Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Fractyl Health, Inc|Bozor kapitallashuvining balans qiymatiga nisbati vTv Therapeutics Inc. (VTVT)|Bozor qiymatining balans qiymatiga nisbati ATPC (agapeatpgroup.com)|PLUR: Bozor qiymatining balans qiymatiga nisbati|Synlogic Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|LPCN - Bozor qiymatining balans qiymatiga nisbati|MTNB - Bozor qiymatining balans qiymatiga nisbati|Spruce Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|GLTO (galecto.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|CTCX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi LUMO|Bozor qiymatining balans qiymatiga nisbati ONVO (Organovo Holdings Inc)|Kapitallashuvning sof aktivlarga nisbati Radius Pharmaceuticals (RDUS)